The Effects of α2-Adrenergic Agonists on the Cardiovascular System

Abstract

Get full access to this article

View all access options for this article.

References

Ahlquist RP : A study of the adrenotropic receptors. Am J Physiol 153:586-600, 1948

Lands AM , Arnold A. , McAuliff JP , et al: Differentiation of receptor systems activated by sympathomimeticamines . Nature 214:597-598, 1967

Bylund DB : Subtypes of alpha1- and alpha2-adrenergic receptors . FASEBJ 6:832-839, 1992

Starke K. , Langer SZ : A note on terminology for presynaptic receptors, in Langer SZ , Starke K , Dubocovich ML (eds): Presynaptic Receptors. Oxford, UK, Pergamon Press, 1979, pp 1-3

Langer SZ : Presynaptic regulation of catecholamine release. Biochem Pharmacol 23:1793-1800,1974

Bloor BC , Schmeling WT : Cardiovascular effects of alpha2-adrenoreceptors. Anesth Pharm Rev 1:246-264, 1993

Berthelsen S. , Pettinger WA : A functional basis for classification of alpha-adrenergic receptors. Life Sci 21:595-606, 1977

Ruffolo RR Jr, Nichols AJ , Stadel JM , Hieble JP : Pharmacologic and therapeutic applications of alpha2-adrenoceptor subtypes. Annu Rev Pharmacol Toxicol 32:243-279, 1993

Unnerstall JR , Kopajtic TA , Kuhar MJ : Distribution of alpha2-agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents. Brain Res 319:69-101, 1984

10.

Vizi ES : Presynaptic modulation of neurochemical transmission. Prog Neurobiol 12:181-290, 1979

11.

Drew GM , Whiting SB : Evidence for two distinct types of postsynaptic alpha-adrenoceptor in vascular smooth muscle in vivo. Br J Pharmacol 67:207-215, 1979

12.

Berthelsen S. , Pettinger WA : A functional basis for classification of alpha-adrenergic receptors. Life Sci 21:595-606, 1977

13.

Unnerstall JR , Kuhar MJ : Mapping the alpha-adrenergic receptor in the central nervous system: A guide to structure and function, in Stolk JM , U'Prichard DC , Fuxe K (eds): Epinephrine in the Central Nervous System. New York, NY, Oxford University Press, 1988, pp 45-59

14.

Bylund DB : Subtypes of alpha-2-adrenoceptors: Pharmacological and molecular biological evidence converge. TIPS 9:356-361, 1988

15.

Maze M. , Scheinin M. : Molecular pharmacology of alpha2adrenergic receptors. Anesth Pharm Rev 1:233-237, 1993

16.

Maze M. , Tranquilli W. : Alpha2-adrenoceptor agonists: Defining the role in clinical anesthesia . Anesthesiology 74:581-605, 1991

17.

Coughlan MG , Lee JG , Bosnjak ZJ , et al: Direct coronary and cerebral vascular responses to dexmedetomidine: Significance of endogenous nitric oxide synthesis . Anesthesiology 77:998-1006, 1992

18.

Aghajanian GK , VanderMaelen CP: Alpha2-adrenoceptor-mediated hyperpolarization of locus coeruleus neurons: Intracellular studies in vivo . Science 215:1394-1396,1982

19.

Correa-Sales C. , Rabin BC , Maze M. : A hypnotic response to dexmedetomidine, an alpha2-agonist, is mediated in the locus coeruleus in rats. Anesthesiology 76:948-952, 1992

20.

Doze VA , Chen B-X. , Maze M. : Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha2-adrenoceptors. Anesthesiology 7175-7179, 1989

21.

Ruffolo RR , Turowski BS , Patil PN : Lack of crossdesensitization between structurally dissimilar alpha-adrenoceptor agonists. J Pharm Pharmacol 29:378-380, 1977

22.

Ruffolo RR , Rice PJ , Patil PN, et al: Differences in the applicability of the Easson-Stedman hypothesis to the alpha1- and alpha2-adrenergic effects of phenethyl-amines and imidazolines. Eur J Pharmacol 86:471-475, 1983

23.

Bousquet P. , Feldman J. , Schwart J. : Central cardiovascular effects of alpha-adrenergic drugs: Differences between catecholamines and imidazolines. J Pharmacol Exp Ther 230:232-236, 1984

24.

Ernsberger P. , Meeley MP , Mann JJ , Reis DJ : Clonidine binds to imidazole binding sites as well as alpha2arenoceptors in the ventrolateral medulla. Eur J Pharmacol 134:1-13, 1987

25.

Regunathan S. , Reis DJ : Imidazoline receptors and their endogenous ligands. Annu Rev Pharmacol Toxicol 36:511-544, 1996

26.

Reis DJ , Morrison S. , Ruggiero DA : The C1 area of the brainstem in toic and reflex control of blood pressure: State of the art lecture. Hypertension 11:18-13, 1988

27.

Bousquet P. , Feldman J. , Tibirica E. , et al: New concepts on the central regulation of blood pressure. Alpha2adrenoceptors and "imidazoline receptors." Am J Med 87:10S-13S, 1989

28.

LehmannJ. , Koenig-Berard E. Vitou P. : The imidazoline-preferring receptor. Life Sci 45:1609-1615, 1989

29.

Guo TZ , Jiang JY , Butterman AE , Maze M. : Dexmedetomidine injection into locus ceruleus produces antinociception. Anesthesiology 84:873-881, 1996

30.

Yamaguchi I. , Kopin IJ : Differential inhibition of alpha-1 and alpha-2 adrenoceptors-mediated pressor responses in pithed rates. J Pharmacol Exp Ther 214:275-281, 1980

31.

Langer SZ , Shepperson NB : Recent developments in vascular smooth muscle pharmacology: The postsynaptic alpha2-adrenoceptor. Trends Pharmacol Sci 3:440-444, 1982

32.

Langer SZ , Shepperson NB : Postjunctional alpha1adrenoceptors and the role of neuronal uptake . J Cardiovasc Pharmacol 4:S8-13 (Suppl 1), 1982

33.

Nichols AJ , Hieble JP , Ruffolo RR : The pharmacology of peripheral alpha1- and alpha2-adrenoceptors . Rev Clin Basic Pharm 7:129-205, 1988

34.

Cavero I. , Shepperson N. , Lefevre-Borg F. , Langer SZ : Differential inhibition of vascular smooth muscle responses to alpha 1- and alpha2-adrenoceptor agonists by diltiazem and verapamil . Circ Res 52:169-176, 1983

35.

van Meel JC , deJonge A. , Kalkman HO , et al: Vascular smooth muscle contraction initiated by postsynaptic alpha2-adrenoceptor activation is induced by an influx of extracellular calcium. Eur J Pharmacol 69:205-208, 1981

36.

van Meel JC , deJonge A. , Kalkman HO , et al: Organic and inorganic calcium antagonists reduce vasoconstriction in vivo mediated by postsynatic alpha2-adrenoceptors . Naunyn Schmiedebergs Arch Pharmacol 316:288-293, 1981

37.

Ruffolo RR : Stereochemical requirements for activation and blockade of alpha1- and alpha2-adrenoceptors. Trends Pharmacol Sci 5:160-164, 1984

38.

Awad R. , Payne R. , Deth RC : Alpha adrenergic receptor subtype associated with receptor binding, Ca++ influx. Ca++ release and contractile events in the rabbit aorta. J Pharmacol Exp Ther 227:60-67,1983

39.

Ruffolo RR Jr : Distribution and function of peripheral alpha-adrenoceptors in the cardiovascular system. Pharmacol Biochem Behav 22:827-833, 1985

40.

MacLean MR , McCulloch KM , McGrath JC : Influences of the endothelium and hypoxia on alpha1 and alpha 2-adrenoceptor-mediated responses in the rabbit isolated pulmonary artery . Br J Pharmacol 108:155-161, 1993

41.

Matsuda H. , Kuon E. , Holtz J. , Busse R. : Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha2-adrenergic agonists. J Cardiovasc Pharmacol 7:680-688, 1985

42.

Cocks TM , Angus JA : Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature 305:627-630, 1983

43.

Egleme C. , Godfraind T. , Miller RC : Enhanced responsiveness of rat isolated aorta to clonidine after removal of the endothelial cells. Br J Pharmacol 81:16-18, 1984

44.

Shimokawa H. , Flavahan NA , Vanhoutte PM : Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries: Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 65:740-753, 1989

45.

Godfraind T. , Egleme C. , Al Osachie I. : Role of endothelium in the contractile response of rat aorta to aphaadrenoceptor agonists. Clin Sci 68:65S-71S(Suppl 1), 1985

46.

Angus JA , Cocks TM , Satoh K. : The alpha adrenoceptors on endothelial cells. Fed Proc 45:2355-2359, 1986

47.

Lues I. , Schumann HJ : Effect of removing the endothelial cells on the reactivity of rat aortic segments to different alpha-adrenoceptor agonists. Naunyn Schmiedebergs Arch Pharmacol 328:160-163, 1984

48.

Devcic A. , Schmeling WT , Kampine JP , et al: Oral dexmedetomidine preserves baroreceptor function and decreases anesthetic requirements of halothane-anesthetized dogs. Anesthesiology 81:419-430, 1994

49.

Haeusler G. : Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn Schmiedebergs Arch Pharmacol 278:231-246, 1973

50.

Muzi M. , Goff DR , Kampine JP , et al: Clonidine reduces sympathetic activity but maintains baroreflex responses in humans. Anesthesiology 77:864-871, 1992

51.

Schmeling WT , Kampine JP , Roerig DL , Warltier DC : The effects of stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology 75:499-511, 1991

52.

Reis DJ , Granata AR , Joh TH , et al: Brain stem catecholamine mechanisms in toic and reflex control of blood pressure. Hypertension 6:115-117, 1984

53.

Proctor LT , Schmeling WT , Roerig D. , et al: Oral dexmedetomidine attenuates hemodynamic responses during emergence from general anesthesia in chronically instrumented dogs. Anesthesiology 74:108-114, 1991

54.

Hausler G. : Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex. Naunyn Schmiedebergs Arch Pharmacol 285:1-14, 1974

55.

Schmitt H. , Schmitt H. : Localization of the hypotensive effect of 2-(2,6-dichloraphenylamine)-2-imidazoline hydrochloride (ST-155, Catapresan). Eur J Pharmacol 6:8-12,1969

56.

Laubie M. , Schmitt H. , Drouillat M. : Action of clonidine on the baroreceptor pathway and medullary sites mediating vagal bradycardia. Eur J Pharmacol 38:293-303, 1976

57.

Drew GM : Effects of alpha-adrenoceptor agonists and antagonists on pre- and postsynaptically located alpha-adrenoceptor. Eur J Pharmacol 36:313-320, 1976

58.

Lin W. , Siedler FJ , McCook EC , Slotkin TA : Overexpression of alpha2-adrenergic receptors in fetal rat heart: Receptors in search of a function. J Dev Physiol 17:183-187, 1992

59.

Eason MG , Liggett SB : Human alpha2-adrenergic receptor subtype distribution: Widespread and subtype selective expression of alpha2C10, alpha2C4, and alpha2C2 mRNA inmultiple tissues. Mol Pharmacol 44:70-75, 1993

60.

Housmans R. : Effects of dexmedetomidine on contractility, relaxation and intracellular calcium transients of isolated ventricular myocardium . Anesthesiology 73:919-922, 1990

61.

Flacke WE , Flacke JW , Blow KD , et al: Effect of dexmedetomidine, an alpha2-adrenergic agonist in the isolated heart. J Cardiovasc Anesth 6:418-423, 1992

62.

Corr PB , Shayman JA , Kramer JB : Increased alpha-adrenergic receptors in ischemic cat myocardium. J Clin Invest 67:1232-1236, 1981

63.

Karliner JS , Barnes P. , Brown M. , Dollery C. : Chronic heart failure in the guinea pig increases cardiac alpha1and beta-adrenoceptors. Eur J Pharmacol 67:115-118, 1980

64.

Bloor BC , Frankland M. , Alper G. , et al: Hemodynamic and sedative effects of dexmedetomidine in dog. J Pharmacol Exp Ther 263:690-697, 1992

65.

Lawrence CJ , Prinzen FW , de Lange S. : The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg 82:544-550, 1996

66.

Jones CJ , DeFily DV , PattersonJL , Chilian WM : Endothelium-dependent relaxation competes with alpha1- and alpha 2-adrenergic constriction in the canine epicardial coronary microcirculation . Circulation 87:1264-1274, 1993

67.

Heusch G. , Deussen A. , Schipke J. , Thamer V. : Alpha1and alpha2-adrenoceptor-mediated vascoconstriction of large and small canine coronary arteries in vivo. J Cardiovasc Pharmacol 6:961-968, 1984

68.

Schulz R. , Oudis RJ , Guth BD , Heusch G. : Minimal alpha1- and alpha2-adrenoceptor-mediated coronary vasconstriction in the anaesthetized swine. Naunyn Schmiedebergs Arch Pharmacol 342:422-428, 1990

69.

Heusch G. , Deussen A. , Schipke J. , et al: Role of cardiac sympathetic nerves in the genesis of myocardial ischemia distal to coronary stenosis. J Cardiovasc Pharmacol 7:S13-18, 1985

70.

Kopia GA , Kopaciewicz LJ , Ruffolo RR : Alpha-adrenoceptor regulation of cornary artery blood flow innormal and stenotic canine coronary arteries. J Pharmacol Exp Ther 239:641-647, 1986

71.

Hotz J. , Saeed M. , Sommer O. , Bassenge E. : Norepinephrine constricts the canine coronary bed via postsynaptic alpha 2-adrenoceptors. Eur J Pharmacol 82:199-202, 1982

72.

Feigl EO : Adrenergic control of transmural coronary blood flow. Basic Res Cardiol 85:167-76 (Suppl 1), 1990

73.

Hori M. , Kitakze M. , Tamai J. , et al: Alpha2-adrenoceptor activity exerts dual control of coronary blood flow in canine coronary artery. Am J Physiol 255:H250-H260, 1988

74.

Gross GJ , Winbury MM : Beta-adrenergic blockade on intramyocardial distribution of coronary blood flow. J Pharmacol 187:451-464, 1973

75.

Seitelberger R. , Guth BD , Heusch G. , et al: Intracoronary alpha2-adrenergic receptor blockade attenuates ischemia in conscious dogs during exercise. Circ Res 62:436-441, 1988

76.

Deussen A. , Busch P. , Schipke J. , et al: Contribution of postsynatic alpha2-adrenoceptors to reflex sympathetic constriction of stenotic coronary vessles. Basic Res Cardiol 85:193-206 (Suppl 1), 1990

77.

Strader JR , Gwirtz PA , Jones CE : Comparative effects of alpha1- and alpha2-adrenoceptors in mediation of coronary flow during exercise. J Pharmacol Exp Ther 246:772-778, 1988

78.

Laxson DD , Dai XZ , Homans DC , Bache RJ : The role of alpha1-and alpha2-adrenergic receptors in mediation of coronary vasoconstriction in hypoperfused ischemic myocardium during exercise. Circ Res 65:1688-1697, 1989

79.

Flacke WE , Flacke JW , Bloor BC , et al: Effects of dexmedetomidine on systemic and coronary hemodynamics in the anesthetized dog. J Cardiovasc Anesth 7:41-49, 1993

80.

Savola JM , Brennan KM , Maze M. , et al: No decrease in myocardial blood flow during infusion of dexmedetomidine as assessed using positron emission tomography in anaesthetized dogs. Eur J Pharmacol 183:360-361, 1990

81.

Proctor LT , Schmeling WT , Warltier DC : Premedication with dexmedetomidine alters hemodynamic actions of intravenous anesthetic agents in chronically instrumented dogs. Anesthesiology 77:554-562, 1992

82.

Kersten J. , Pagel PS , Tessmer JP , et al: Dexmedetomidine alters the hemodynamic effects of desflurane and isoflurane in chronically instrumented dogs. Anesthesiology 79:1022-1032, 1993

83.

KerstenJ. , Pagel PS , Hettrick DA , Warltier DC : Dexmedetomidine partially attenuates the sympathetically mediated systemic and coronary hemodynamic effects of cocaine. Anesth Analg 80:114-121, 1995

84.

Indolfi C. , Piscioni F. , Villari B. , et al: Role of alpha2adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation 86:1116-1124, 1992

85.

Kono M. , Morita S. , Hayasni T. , et al: The effects of intravenous colonidine on regional myocardial function in a canine model of regional myocardial ischemia. Anesth Analg 78:1047-1052, 1994

86.

Schmeling WT , Farber NE : Anesthetic actions on cardiovascular control mechanisms in the central nervous system. Adv Pharmacol 31:617-642, 1994

87.

Antonaccio MJ : Neuropharmacology of central mechanisms governing the circulation, in Antonaccio M (ed): Cardiovascular Pharmacology. New York, NY , Raven, 1977, pp 131-165

88.

Calaresu FR , Thomas MR : Electrophysiological connections in the brain stem involved in cardiovascular regulation. Brain Res 87:335-338, 1975

89.

Calaresu FR , Ciriello J. : Electrophysiology of the hypothalamus in relation to central regulation of the cardiovdascular system, in Meyer P, Schmitt H, (eds): Brain and Hypertension. 1979 , pp 129-136

90.

Schmeling WT , Hosko MJ , Hardman HF : Potentials evoked in the intermediolateral column by hypothalamic stimulation-supression by Delta9-tetrahydrocannabinol . Life Sci 29:673-680, 1981

91.

Poterack KA , Kampine JP , Schmeling WT : Effects of isoflurane, midazolam, and etomidate on cardiovascular responses to stimulation of central nervous system pressor sites in chronically instrumented cats. Anesth Analg 73:64-75, 1991

92.

Guyenet PG : Role of the ventral medulla oblongata in blood pressure regulation, in Loewy AD , Spyer KM (eds): Central Regulation of Autonomic Functions. New York, NY, Oxford University Press, 1990, pp 145-167

93.

Ross CA , Ruggiero DA , Park DH , et al: Tonic vasomotor control by the rostral ventrolateral medulla: Effect of electrical or chemical stimulation of the area containing C 1-adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci 4:474-494, 1984

94.

Ciriello J. , Caverson MM , Polosa C. : Function of the ventrolateral medulla in the control of the circulation. Brain Res 396:359-391, 1986

95.

Calaresu FR , Ciriello J. , Caverson MM , et al: Functional neuroanatomy of central pathways controlling the circulation, in Guthrie GP Jr , Kotchen TA (eds): Hypertension and the Brain . Mount Kisco, NY, Futura Publishing Co, 1984, pp 3-21

96.

Ross CA , Ruggiero DA , Reis DJ : Afferent projections to cardiovascular portions of the nucleus of the tractrus solitarius in the rat. Brain Res 223:402-408, 1981

97.

Spyer KM : Neural organisation and control of the baroreceptor reflex. Rev Physiol Biochem Pharmacol 88:24-124, 1981

98.

Ross CA , Ruggiero DA , Reis DJ : Projections from the nucleus tractus solitarii to the rostral ventrolateral medulla. J Comp Neural 242:511-534, 1985

99.

Isaac L. : Clonidine in the central nervous system: Site and mechanism of hypotensive action. J Cardiovasc Pharmacol 2:S5-19 (Suppl 1 ), 1980

100.

Halson DW , Riddell JG , Shanks RG : Effects of azepexole and clonidine on baroreceptor-mediated reflex bradycardia and physiological tremor in man. Br J Clin Pharmacol 20:431-436, 1985

101.

Spiers JP , Harron DW , Wilson R. : Acute and chronic effects of rilmenidine on baroreflex function in conscious dogs. Eur J Pharmacol 181:235-240, 1990

102.

Farber NE , Samso E. , Schwabe D. , Schmeling WT : Dexmedetomidine modulates cardiovascular responses to stimulation of central nervous system pressor sites in cats anesthetized with halothane. Anesth Analg 78(2S): S106, 1994

103.

Tranquilli WS , Maze M. : Clinical pharmacology and use of alpha 2-adrenergic agonists in veterinary anaesthesia. Anesth Pharm Rev 1:297-309, 1993

104.

Jakola ML , Ali-Melkkila T. , Kanto J. , et al: Dexmedetomidine reduces intraoccular pressure, intubation responses and anesthetic requirements in patients undergoing ophthalmic surgery. Br J Anaesth 68:570-575, 1992

105.

Ghignone M. , Quintin L. , Duke PC , et al: Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endeotracheal intubation. Anesthesiology 64:36-42, 1986

106.

Flacke JW , Bloor BC , Flacke WE , et al: Reduced narcotic requirement by clondine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology 67:11-19, 1987

107.

Bloor BC , Flacke WE : Reduction in halothane anesthetic requirement by clonidine, an alpha-adrenergic agonist. Anesth Analg 41:741-745, 1982

108.

Ghignone M. , Calvillo O. , Quintin L. : Anesthesia and hypertension: The effect of clonidine on perioperative hemodynamics and isoflurane requirements. Anestheisology 67:3, 1987

109.

Kenny D. , Pelc LR , Brooks HL , et al: Alterations of alpha1- and alpha2-adrenoceptor—mediated pressor responses by halothane and isoflurane anesthesia. Anesthesiology 71:224-234, 1989

110.

Foote SL , Bloom FE , Aston-Jones G. : Nucleus locus coeruleus: New evidence of anatomical and physiological specificity . Phys Rev 63:844-914, 1983

111.

James IM , Larbi E. , Zaimis E. : The effect of the acute intravenous administration of clonidine on cerebral blood flow in man. Br J Pharmacol 39:198P-199P, 1970

112.

Greene CS , Cretier DD , Cervenka K. , et al: Cerebral blood flow during the acute theraphy of severe hypertension with oral clonidine. Am J Emerg Med 8:293-296, 1990

113.

Kanawati IS , Yaksh TL , Anderson RE , Marsh RW : Effects of clonidine on cerebral blood flow and the response to arterial CO2. J Cereb Blood Flow Metab 6:358-365, 1986

114.

Karlsson BR , Forsman M. , Roald OK , et al: Effect of dexmedetomidine, a selective and potent alpha2- agonist, or cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 71:125-129, 1990

115.

Zornow MH , Fleischer JE , Scheller MS , et al: Dexmedetomidine, and alpha2-adrenergic agonist, decreases cerebral blood flow in the isoflurane-anesthetized dog. Anesth Analg 70:623-630, 1990

116.

McPherson RW, Kirsch JR , Traystman RJ : Inhibition of nitric oxide synthetase does not affect alpha2-adrenergic-mediated cerebral vasoconstriction. Anesth Analg 78:67-72, 1994

117.

McPherson RW , Koehler RC , Traystman RJ : Hypoxia, alpha2-adrenergic, and nitric oxide-dependent interactions on canine cerebral blood flow. Am J Physiol 226:H476-H482,1994

118.

Ishiyama T. , Dohi S. , Iida H. , et al: Mechanisms of dexmedetomidine-induced cerebrovascular effects in canine in vivo experiments. Anesth Analg 81:1208-1215, 1995

119.

Smith JJ , Samso E. , Hudetz B. , et al: Dexmedetomidine: Effect on laser Doppler flow in the rat cerebral cortex. Anesthesiology 81:695, 1994

120.

O'Brien WW , Coughlan M. , Schmeling WT , et al: Differential effects of halothane and isoflurane on isolated cerebral artery segments contracted with dexmedetomidine . Anesthesiology 81:696, 1994

121.

Maier C. , Steinberg GK , Sun GH , et al: Neuroprotection by the alpha2-adrenoreceptor agonist dexmedetomidine in a focal model of crebral ischemia. Anesthesiology 79:306-312, 1993

122.

Hoffman WE , Kochs E. , Werner C. , et al: Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rate: Reversal by the alpha2 -adrenergic antagonist atipamezole. Anesthesiology 75: 328-332,1991

123.

Kim HK , Zornow MH , Stranat Map : Dexmedetomidine does not attentuate increases in excitatory amino acids after transient global ischemia in the rabbit. Anesthesiology 81:A8777, 1994

124.

Mangano DT , Hollenberg M. , Fegert G. , et al: SPI Research Group. Peri-operative myocardial ischemia in patients undergoing non-cardiac surgery. I: Incidence and severity during the 4 day peri-operative period. J Am Coll Cardiol 7:843-850, 1991

125.

Talke PO , Mangano DT : Alpha2-adrenergic agonists and peri-operative ischaemia. Anesth Pharm Rev 1:297-309, 1993

126.

Bonnet F. , Liu R. : Delaunayl: Non-spinal use of alpha2adrenergic agonists for pain therapy. Anesth Pharm Rev 1:284-287, 1993

127.

Ossipov MH , Gebhart GF : Absence of antinociceptive effect of alpha 2-agonists microinjected in periaqueductal gray of the rat. Brain Res 289:349-354, 1983

128.

Spaulding TC , Venafro JJ , Ma MG , Fielding S. : The dissociation of the antinociceptive effect of clonidine from suprasprinal structures. Neuro Pharmacol 18:103-105,1979

129.

Aho M. , Lehtinen AM , Erkola O. , et al: The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology 74:997-1002, 1991

130.

Aho M. , Scheinin M. , Lehtinen AM , et al: Intramuscularly administered dexmedetomidine attentuates hemodynamic and stress horomone responses to gynecologic laparoscopy. Anesth Analg 75:932-939, 1992

131.

Aantaa R. , Kanto J. , Scheinin M. , et al: Dexmedetomidine, an alpha2-adrenoreceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 73:230-235, 1990

132.

Bonnet F. , Bioco O. , Rostaing S. , et al: Clonidine-induced analgesia in postoperative patients: Epidural versus intramuscular administration. Anesthesiology 72:423-427, 1990

133.

Aho MS , Olli A. , Scheinin H. , et al: Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 73:112-118, 1991

134.

Segal IS , Jarvis DJ , Duncan SR , et al: Clinical efficacy or oral-transdermal clonidine combination during the postoperative period. Anesthesiology 74:220-225, 1991

135.

Kuraishi Y. , Hirota N. , Sato Y. , et al: Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn . Brain Res 259:177-182, 1985

136.

Reddy Svr , Yaksh TL : Spinal noradrenergic terminal system mediates antinociception. Brain Res 189:391-401,1980

137.

Sabbe MB , Penning JP , Ozaki AS , Yaksh TL : Spinal and systemic action of the alpha2-receptor agonist dexmedetomidine in dogs. Anesthesiology 80:1057-1072, 1994

138.

Murata K. , Nakagawa I. , Kumela Y. , et al: Intrathecal clonidine suppres noxiously evoked activity of spinal wide dynamic range neurons in cats. Anesth Analg 69:185-191,1989

139.

Jackson C. , Eisenach JC : Spinal administration of alpha2adrenergic agonists. Anesth Pharm Rev 1:288-296, 1993

140.

Mendez R. , Eisenach JC, Kastank : Epidural clonidine analgesia after cesarean section. Anesthesiology 73:848-852, 1990

141.

Coombs DW , Jensen LB , Murphy C. : Microdose intrathecal clonidine and morphine for postoperative analgesia. Anesthesiology 67:A238, 1987

142.

Samso E. , Farber NF , Schwabe D. , et al: Dexmedetomidine attenuates the somatosymapthetic reflex via spinal mechanisms. Anestheisology 81:A938, 1994

143.

Weinger MB , Segal IS , Maze M. : Dexmedetomidine, acting through central alpha 2-adrenoceptors, prevents opiate-induced muscle rigidity in the rat . Anesthesiology 71:242-249, 1989

144.

Schmeling WT , Kampine JP , Warltier DC : Dexmedetomidine attenuates the "shivering" upon the emergence from halothane anesthesia in chronically instrumented cats. Anesth Analg 74:S264, 1992

145.

Glynn CJ : The spinal noradrenergic systems in the transmission of pain in patients, in Besson JM , Guilbaud G (eds): Towards the Use of Noradrenergic Agonists for the treatment of Pain. Excepta Medica Internaional Congress Series 1006. Amsterdam, Elsevier Science Publishers, 1992, pp 197-210

146.

Gold MS , Pottash AC , Extein I. : Clonidine and opiate withdrawal. Lancet 2:1078-1079, 1980

147.

Gold MS , Redmond DE , Kleber HD : Clonidine blocks acute opiate withdrawal symptoms. Lancet 2:599-602, 1978

148.

Glassman AH , Jackson WK , Walsh BT , et al: Cigarette craving, smoking withdrawal, and clonidine. Science 226:864-866, 1984

149.

Tierney C. , Nadaud D. , Koenig-Berard E. , Stinus L. : Effects of two alpha2-agonists, rilmedidine and clonidine, on the morphine withdrawal systems and their potential addictive properties in rats. Am J Cardiol 61:35D-38D, 1988

150.

Gossop M. : Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend 21:253-259, 1988

151.

Kamibayashi T. , Hayashi Y. , Mammoto T. , et al: Role of the vagus nerve in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83:992-999, 1995

152.

Rotenberg FA , Verrier RL , Lown B. , Sole MJ : Effects of clonidine on vulnerability to fibrillation in the normal and ishemic canine ventricle. Eur J Pharmacol 47:71-79, 1978

153.

Chen SA , Lin RH , Ting TH , et al: Termination of digitalis-induced ventricular tachycardias by clonidine involves central alpha2-adrenoceptors in cats. BrJ Pharmacol 103:1114-1118, 1991

154.

Kamibayashi T. , Mammotot, Hayashi Y , et al: Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/epinephrine dysrhythmias in dogs. Anesthesiology 83:1082-1089, 1995